Treatment indication, n (%)
Risk of functional impairment
Discomfort due to ulceration
Cosmetic disfigurement
|
3 (21.4%)
1 (7.1%)
10 (71.4%)
|
Age of propranolol initiation
months
1-2 months
3-6 months
6-12 months
>12 months
|
0
7 (50.0%)
5 (35.7%)
2 (14.3%)
0
|
Propranolol dosage
1 mg/kg/d
2 mg/kg/d
2.5 mg/kg/d
4 mg/kg/d
|
0
13 (92.9%)
1 (7.1%)
0
|
Total length of propranolol treament, mean (range) [SD]
<3 weeks
3-6 weeks
6-12 weeks
3-6 months
>6 months
|
7.6 (4 to 18) [3.9]
0
0
0
3 (21.4%)
11 (78.6%)
|
Initial propranolol Response
None
Partial
Nearly Complete
Complete
|
0
8 (57.1%)
6 (42.9%)
0
|
Adverse Events
Irritability/agitation
|
1 (7.1%)
|
Laser Therapy, n (%) |
0 |
Surgical Excision, n (%) |
0 |
Corticosteroid Treatment, n (%) |
0 |